Claudio Cacchi

Dr. Claudio Cacchi


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2021 in Cells
Verified
Journal Article
Open access
PDF file
DWDickson W.L. Wong
Dickson W.L. Wong
BKBarbara M. Klinkhammer
Barbara M. Klinkhammer
SDSonja Djudjaj
Sonja Djudjaj
SVSophia Villwock
Sophia Villwock
MTM. Cherelle Timm
M. Cherelle Timm
PBPeter Boor
Peter Boor
Multiorgan tropism of SARS-CoV-2 has previously been shown for several major organs. We have comprehensively analyzed 25 different formalin-fixed paraffin-embedded (FFPE) tissues/organs from autopsies of fatal COVID-19 cases (n = 8), using histopathological assessment, detection of SARS-CoV-2 RNA using polymerase chain reaction and RNA in situ hybridization, viral protein using immunohistochemistry, and virus particles using transmission electron microscopy. SARS-CoV-2 RNA was mainly localized in epithelial cells across all organs. Next to lung, trachea, kidney, heart, or liver, viral RNA was also found in tonsils, salivary glands, oropharynx, thyroid, adrenal gland, testicles, prostate, ovaries, small bowel, lymph nodes, skin and skeletal muscle. Viral RNA was predominantly found in cells expressing ACE2, TMPRSS2, or both. The SARS-CoV-2 replicating RNA was also detected in these organs. Immunohistochemistry and electron microscopy were not suitable for reliable and specific SARS-CoV-2 detection in autopsies. These findings were validated using in situ hybridization on external COVID-19 autopsy samples (n = 9). Apart from the lung, correlation of viral detection and histopathological assessment did not reveal any specific alterations that could be attributed to SARS-CoV-2. In summary, SARS-CoV-2 and its replication could be observed across all organ systems, which co-localizes with ACE2 and TMPRSS2 mainly in epithelial but also in mesenchymal and endothelial cells. Apart from the respiratory tract, no specific (histo-)morphologic alterations could be assigned to the SARS-CoV-2 infection.

15 November 2021 in Current Oncology
Verified
Journal Article
Open access
PDF file
MLMarike Leijs
Marike Leijs
HSHannah Marie Schaefer
Hannah Marie Schaefer
ARAlbert Rübben
Albert Rübben
CCClaudio Cacchi
Claudio Cacchi
TRThomas Rustemeyer
Thomas Rustemeyer
SBSebastiaan van der Bent
Sebastiaan van der Bent
Background: A variety of side effects following the tattooing of the skin were reported over the years. Analytical studies showed that some tattoo inks contain harmful compounds. Methods: We presented six patient cases with cutaneous malignancies in tattooed skin and performed an extensive literature research. Results: Two patients with black ink tattoos that were diagnosed with malignant melanoma raises the number of described cases to 36 patients. One of the patients developed an immunologic reaction limited to the tattoo area after treatment with a targeted immune therapy. In the other patient, the malignancy (malignant melanoma) was fatal. Basal cell carcinoma was seen in four patients with tattoos containing varying ink colors (black, green, red). This increased the number of described patient cases to 18. Although some ink components and their cleavage products have carcinogenic properties, epidemiological evidence for a causative correlation fails. Further epidemiologic studies on tattoos and malignancies, as well as on the appearance of naevi in tattoos, are necessary. Determining the type of mutation might be helpful to separate sun-induced tumors from skin cancers due to other pathogenic mechanisms.

30 January 2024 in Cancers
Verified
Journal Article
Open access
PDF file
CCClaudio Cacchi
Claudio Cacchi
HFHenrike Fischer
Henrike Fischer
KWKai Wermker
Kai Wermker
ARAshkan Rashad
Ashkan Rashad
DJDanny Jonigk
Danny Jonigk
MKMaurice Klein
Maurice Klein
Background: Tumor budding (TB) is a histomorphological characteristic of the tumor invasion front and it has an impact on the tumor outcome prediction for head and neck squamous cell carcinoma (HNSCC) aetiopathology. Patients and methods: The average TB score (TB rel) of all tumor-positive marginal sections (n = 443) in the primary tumor was analyzed in the FFPE-fixed tumor slices of 66 patients with HNSCC, and they were compared with cryo-fixed sections. Results: TB rel correlates with tumor aggressiveness (i.e., lymph node metastasis quantity, lymph node ratio, extra capsular growth, Pn1, pV1, grading). The TB scores often vary between the different tumor margins of FFPE sections in the same patient, and in many cases, they differ depending on the fixation method. Conclusion: Our data show that a randomly selected marginal cut cannot reliably mirror the TB score, and thus, they cannot predict the prognostic outcome. However, TB rel could be a tool that compensates for differences in TB score analysis. TB score determination in cryo sections seems to be inaccurate compared with TB determination in FFPE.

28 March 2022 in Acta Dermato-Venereologica
Verified
Journal Article
Open access
NANicole Albuscheit
Nicole Albuscheit
DKDavid Kluwig
David Kluwig
CCClaudio Cacchi
Claudio Cacchi
MOMyriam Ohler
Myriam Ohler
AYAmir S. Yazdi
Amir S. Yazdi

19 April 2026 in Cells
Verified
Journal Article
Open access
PDF file
SHSofie-Yasmin Hassan
Sofie-Yasmin Hassan
SSSimeon Santourlidis
Simeon Santourlidis
TFThomas W. Flanagan
Thomas W. Flanagan
SHSarah-Lilly Hassan
Sarah-Lilly Hassan
HZHe Zhou
He Zhou
Mohamed HassanMohamed Hassan
Mohamed Hassan
Head and neck mucosal melanoma (HNMM) arises in the nasal and oral cavities and has the propensity to metastasize to local and distant body sites. HNMM is also notable for its resistance to available therapeutics. The rarity of this disease makes it difficult to conduct large-scale clinical studies to develop standard treatment protocols. In contrast to cutaneous melanoma, c-Kit-dependent pathways are well studied in HNNMM and provide a potential therapeutic target. We identified and isolated genetically distinct subpopulations with stem cell characteristics in HNMM samples bearing Kit wild-type and mutations. Functional analysis of these subpopulations reveals that, in addition to expressing the stem cell marker proteins CD20, CD117, CD133, and CD166, these subpopulations are characterized by self-renewal potential, migratory capacity, and resistance to Kit inhibitors such as Imatinib. Immunofluorescence staining and inhibition experiments demonstrate that the maintenance and resistance of HHMM subpopulations to Kit inhibitors is mediated by the Kit signal to the PI3K signaling pathway. The KIT signal to the PI3K signaling pathway does not result exclusively from a KIT mutation localized to Exon 17, but can also be triggered by mutations localized to Exons 11 and 13. In the present study, we identify and characterize an HNMM subpopulation with stemness properties in patients with c-Kit wild-type and mutation, and demonstrate for the first time the mechanisms by which the CD117+/CD133+ HNMM subpopulations survive and confer resistance to the specific inhibitor of c-Kit mutation.

14 September 2026 in Archives of Oral Biology
Verified
Journal Article
Open access
MKMaurice Klein
Maurice Klein
JRJanik Riese
Janik Riese
SLS. Leypold
S. Leypold
KWK. Wermker
K. Wermker
MKMarie Sophie Katz
Marie Sophie Katz
CCClaudio Cacchi
Claudio Cacchi
Metastasis suppressor protein 1 (MTSS1) has been investigated as a marker of tumor aggressiveness across various tumor entities but remains poorly studied in head and neck squamous cell carcinoma. Its role in lip squamous cell carcinoma has not yet been investigated. Given the higher risk of lymphatic metastasis in lip squamous cell carcinoma compared with cutaneous squamous cell carcinoma, identifying associated immunohistochemical markers may provide clinically relevant insights into tumor progression. The tumour marker MTSS1 was examined immunohistochemically on FFPE sections from (n = 49) patients using MTSS1 expression and MTSS1 intensity analysis. The results were then correlated with clinical-pathological characteristics and follow-up outcome parameters. There was a correlation between MTSS1 expression (%) and ASA-score (surrogate of patient frailty) (p = 0.0139), the risk of local recurrence (p = 0.0125) and pV status (p = 0.0347). MTSS1 correlates with local tumor aggressiveness factors, local recurrence during-follow up and, given the small cohort size, should be investigated further in follow-up studies. This hypothesis-generating study may provide a basis for future investigations.